Artiva Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-venBio Global Strategic Fund III, L.P.(6.3%),venBio Global Strategic GP III, L.P.(6.3%), etc.
Artiva Biotherapeutics | 10-Q: Quarterly report
Artiva Biotherapeutics | 8-K: Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director MOORE ALISON
Artiva Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Director MOORE ALISON
Artiva Biotherapeutics | 8-K: Current report
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Raymon Heather
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Graef Thorsten
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Horan Christopher
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bush Jennifer
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Krishnamohan Neha
Artiva Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(40.6%),Peter Kolchinsky(40.6%), etc.
Artiva Biotherapeutics | 10-Q: Quarterly report
Artiva Biotherapeutics | 8-K: Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Artiva Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-venBio Global Strategic Fund III, L.P.(7.8%),venBio Global Strategic GP III, L.P.(7.8%), etc.
Artiva Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Andrew J. Schwab(10.1%),Kush Parmar(10.1%), etc.
Artiva Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Venrock Healthcare Capital Partners III, L.P.(6.9%),VHCP Co-Investment Holdings III, LLC(6.9%), etc.
Artiva Biotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(42.3%),Peter Kolchinsky(42.3%), etc.
Artiva Biotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-GC Corp.(19.6%),Yong-Jun Huh(19.6%), etc.
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
No Data
No Data